We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Exploring Analyst Estimates for Globe Life (GL) Q1 Earnings, Beyond Revenue and EPS
Read MoreHide Full Article
In its upcoming report, Globe Life (GL - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $2.80 per share, reflecting an increase of 10.7% compared to the same period last year. Revenues are forecasted to be $1.43 billion, representing a year-over-year increase of 5.6%.
Over the last 30 days, there has been an upward revision of 0.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
That said, let's delve into the average estimates of some Globe Life metrics that Wall Street analysts commonly model and monitor.
The combined assessment of analysts suggests that 'Revenue- Total premium' will likely reach $1.15 billion. The estimate suggests a change of +5% year over year.
The consensus among analysts is that 'Revenue- Net investment income' will reach $278.13 million. The estimate indicates a change of +8.2% from the prior-year quarter.
According to the collective judgment of analysts, 'Revenue- Health premium' should come in at $344.19 million. The estimate indicates a year-over-year change of +6.7%.
The average prediction of analysts places 'Revenue- Life premium' at $805.41 million. The estimate points to a change of +4.3% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Insurance Underwriting Income- Life' of $311.33 million. The estimate is in contrast to the year-ago figure of $291.27 million.
Analysts forecast 'Insurance Underwriting Income- Health' to reach $96.31 million. Compared to the present estimate, the company reported $91.33 million in the same quarter last year.
Globe Life shares have witnessed a change of -49.2% in the past month, in contrast to the Zacks S&P 500 composite's -1.1% move. With a Zacks Rank #2 (Buy), GL is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Exploring Analyst Estimates for Globe Life (GL) Q1 Earnings, Beyond Revenue and EPS
In its upcoming report, Globe Life (GL - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $2.80 per share, reflecting an increase of 10.7% compared to the same period last year. Revenues are forecasted to be $1.43 billion, representing a year-over-year increase of 5.6%.
Over the last 30 days, there has been an upward revision of 0.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
That said, let's delve into the average estimates of some Globe Life metrics that Wall Street analysts commonly model and monitor.
The combined assessment of analysts suggests that 'Revenue- Total premium' will likely reach $1.15 billion. The estimate suggests a change of +5% year over year.
The consensus among analysts is that 'Revenue- Net investment income' will reach $278.13 million. The estimate indicates a change of +8.2% from the prior-year quarter.
According to the collective judgment of analysts, 'Revenue- Health premium' should come in at $344.19 million. The estimate indicates a year-over-year change of +6.7%.
The average prediction of analysts places 'Revenue- Life premium' at $805.41 million. The estimate points to a change of +4.3% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Insurance Underwriting Income- Life' of $311.33 million. The estimate is in contrast to the year-ago figure of $291.27 million.
Analysts forecast 'Insurance Underwriting Income- Health' to reach $96.31 million. Compared to the present estimate, the company reported $91.33 million in the same quarter last year.
View all Key Company Metrics for Globe Life here>>>
Globe Life shares have witnessed a change of -49.2% in the past month, in contrast to the Zacks S&P 500 composite's -1.1% move. With a Zacks Rank #2 (Buy), GL is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>